PULM (pulmatrix.com) Bozor qiymatining balans qiymatiga nisbati

Pulmatrix Inc (PULM) kompaniyasining rasmiy ramzlari

Pulmatrix, Inc. (PULM) kompaniyasining kunlik narxlar grafigi, uning biofarmatsevtika operatsiyalari barqaror talabga tayanadi, ammo uzluksiz xomashyo importiga bog'liq, 3.29 qiymatini aks ettiradi. Respirator qurilmalar segmentida firma resurslari boy texnologik gigantlar bilan bozor ulushi uchun raqobatlashmoqda, shu bilan birga biznes patent muddatining tugashi natijasida kelib chiqadigan foydalar vaqti va joriy katta miqdordagi tadqiqot xarajatlari bo'yicha noaniqlikka duch kelmoqda.

PULM Pulmatrix Corporation: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 27.10.2026 oraligʻida

Pulmatrix Inc (PULM) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Pulmatrix, Inc.|PULM - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Pulmatrix Corp|PULM - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Pulmatrix|PULM - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati pulmatrix.com|PULM - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Pulmatrix, Inc.|PULM - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Pulmatrix Corp|PULM - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Pulmatrix Corp
Kompaniyaning dastlabki tahlili:Pulmatrix, Inc. - PULM
Pulmatrix Corp original mahsuloti

Investor aktivning xavfsizlik zaxirasini bozor narxini haqiqiy sof aktiv qiymati bilan solishtirish orqali aniqlaydi. Pulmatrix, Inc. (PULM) kompaniyasining farmatsevtika yo'nalishidagi robototexnikasi balans qiymatiga ta'sir qiluvchi yuqori texnologik aktivlar bazasini yaratadi. Bozor qiymatining balans qiymatiga nisbati tendentsiyasi kapitalga nisbatan premium yoki diskont koeffitsiyentini ko'rsatadi. Bir birlikdan yuqori qiymat kelgusidagi daromadlar bo'yicha bozor ishonchini tasdiqlaydi, past daraja esa aktivning qadrsizlanganligini anglatadi. Ushbu metrika aktivni fundamental xavf darajasiga qarab tasniflaydi.

Asosiy raqobatchilar

HLN (Haleon plc) - Bozor qiymatining balans qiymatiga nisbati|KVUE (kenvue.com) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati PRGO (Perrigo Company plc)|alvotech.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Liquidia (LQDA)|GLPG: Balans qiymatiga nisbatan bozor qiymati|ANIP (ANI Pharma) - Bozor qiymatining balans qiymatiga nisbati|Afrezza (MNKD) - Kapitallashuvning sof aktivlarga nisbati|AMPH (Amphastar Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati pacira.com (PCRX)|ARS Pharmaceuticals, Inc. (SPRY) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TBPH (Theravance Biopharma Inc)|AQST: Bozor qiymatining balans qiymatiga nisbati|SCPH - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tectonic TECX|TNXP - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati sxtchina.com SXTC|Eupraxia Pharmaceuticals Inc. (EPRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati BHST (BioHarvest)|Bozor qiymatining balans qiymatiga koeffitsiyenti EXOZ|Oramed Pharmaceuticals (ORMP) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ENTX (enterabio.com)|MindWalk Holdings Inc. (HYFT) - Bozor qiymatining balans qiymatiga nisbati|ABVC - Sof aktivlarga nisbatan bozor kapitallashuvi|Cumberland Pharma - Kapitallashuvning sof aktivlarga nisbati|QNTM: Bozor kapitallashuvining balans qiymatiga nisbati|FibroGen, Inc. (FGEN) - Bozor qiymatining balans qiymatiga nisbati|TELO (telomirpharma.com) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati RANI|Kapitallashuvning sof aktivlarga nisbati Synergy CHC Corporation|Bozor kapitallashuvining balans qiymatiga nisbati RLYB|Bozor kapitallashuvining balans qiymatiga nisbati lexariabioscience.com LEXX|Kapitallashuvning sof aktivlarga nisbati Pheton Holdings (PTHL)|Aptorum Group Ltd - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati Lyra Therapeutics (LYRA)|IBO - Balans qiymatiga nisbatan bozor qiymati|tnfpharma.com - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi cbdMD|Kapitallashuvning sof aktivlarga nisbati PainReform Ltd. (PRFX)|Kapitallashuvning balans qiymatiga nisbati Auris Medical (CYTO)|Lipella Pharmaceuticals, Inc. (LIPO) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati OptiNose Inc (OPTN)|Bozor kapitallashuvining balans qiymatiga nisbati PIRS|Procaps Group Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|Petros Pharmaceuticals (PTPI) - Bozor qiymatining balans qiymatiga nisbati|QLI - Kapitallashuvning balans qiymatiga nisbati|SLRN (ACELYRIN) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati TFF Pharmaceuticals Inc.